Skip to main content
Gufic BioSciences Ltd. logo

Gufic BioSciences Ltd. — Investor Relations & Filings

Ticker · GUFICBIO ISIN · INE742B01025 LEI · 3358003C6YDH6EIDBP63 BSE.NS Manufacturing
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2025-06-27 Regulatory Filings
Country IN India
Listing BSE.NS GUFICBIO

About Gufic BioSciences Ltd.

https://gufic.com/

Gufic BioSciences Ltd. focuses on the research, development, and large-scale manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. The organization is distinguished by its specialized expertise in lyophilization technology, operating extensive facilities for the production of freeze-dried injectables. Its product portfolio encompasses a wide range of therapeutic areas, including critical care, infertility, oncology, and gastroenterology. In addition to conventional medicine, the company develops proprietary herbal and ayurvedic formulations through integrated scientific research. Gufic emphasizes advanced drug delivery systems and maintains a significant presence in the production of antibiotics, antifungal agents, and cardiac medications. The company serves a global clientele by providing high-quality generic and specialty healthcare solutions.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the closure of the trading window for insiders ahead of the announcement of the company's unaudited quarterly financial results. It references compliance with SEBI regulations on insider trading and mentions the upcoming board meeting to approve the unaudited financial results for the quarter ended June 30, 2025. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or statements. It is an announcement related to the timing of financial results disclosure and trading restrictions, not the financial report or earnings release itself. Given the short length (1523 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) since it is a compliance-related announcement that does not fit other specific categories like Earnings Release or Interim Report.
2025-06-27 English
Written Transcript of Earnings Conference Call held on June 02, 2025 at 04:30 p.m. is attached herewith
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the availability of a written transcript of an earnings conference call held on June 02, 2025. It references a prior intimation about the earnings call and provides a link to the transcript on the company's website. The document itself does not contain the transcript but announces its publication. Given the short length (1176 characters) and the nature of the content (announcement of transcript availability), this fits the category of a Regulatory Filing (RNS) rather than the full Call Transcript (CT).
2025-06-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the availability of a written transcript of an earnings conference call held on June 02, 2025. It references a prior intimation about the earnings call and provides a link to the transcript on the company's website. The document itself does not contain the transcript or financial data but serves as a notification of the transcript's publication. Given the short length (1176 characters) and the nature of the content (announcement of transcript availability), this fits the criteria for a Regulatory Filing (RNS) rather than a full Call Transcript (CT) or Earnings Release (ER).
2025-06-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is a short notice addressed to stock exchanges regarding the audio recording of an earnings conference call. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides a link to the audio recording of the earnings call held on June 2, 2025. It also mentions that a written transcript will be submitted later. The document does not contain the transcript itself or detailed financial data, but is an announcement about the availability of the earnings call recording. Given the short length (1226 characters) and the nature of the content, this is an announcement related to a call transcript, not the transcript itself. Therefore, the appropriate classification is Call Transcript (CT) because the document is about the earnings call and its transcript, but since the transcript is not included yet, it is best classified as CT with moderate confidence.
2025-06-02 English
Audio Recording of Earnings Conference Call is attached herewith.
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the audio recording of an earnings conference call held on June 2, 2025. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document states that the audio recording has been uploaded and that a written transcript will be submitted later. There is no actual transcript or financial data included in this document, only an announcement about the availability of the audio recording and future transcript. According to the rules, announcements about conference calls or transcripts without the full transcript text should be classified as Regulatory Filings (RNS) because it is a regulatory disclosure notice rather than the transcript itself. The document length is short (1226 characters), supporting that it is an announcement rather than a full transcript or report.
2025-06-02 English
Newspaper Advertisement of Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2025 is attached herewith
Earnings Release Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the publication of audited financial results for the quarter and financial year ended March 31, 2025. It includes extracts of standalone and consolidated audited financial results, with detailed financial figures and notes. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that the full audited financial results are available on the stock exchange and company websites. The content is a newspaper advertisement of audited financial results, which is a formal disclosure of financial performance but not the full annual report itself. Given the detailed financial data and the nature of the document as an official announcement of audited financial results, it aligns best with an Earnings Release (ER) rather than a full Annual Report (10-K) or Regulatory Filing (RNS). The document is substantial in length (15,000 characters) and contains actual financial data, supporting classification as an Earnings Release. FY 2025
2025-05-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.